Abi Hyde

Abi Hyde

Auto-generated profile, based on publicly available information

Abi Hyde

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMolly Went
Molly Went
ASAmit Sud
Amit Sud
CMCharlie Mills
Charlie Mills
AHAbi Hyde
Abi Hyde
RCRichard Culliford
Richard Culliford
Richard HoulstonRichard Houlston
Richard Houlston
For many cancers there are only a few well-established risk factors. Here, we use summary data from genome-wide association studies (GWAS) in a Mendelian randomisation (MR) phenome-wide association study (PheWAS) to identify potentially causal relationships for over 3,000 traits. Our outcome datasets comprise 378,142 cases across breast, prostate, colorectal, lung, endometrial, oesophageal, renal, and ovarian cancers, as well as 485,715 controls. We complement this analysis by systematically mining the literature space for supporting evidence. In addition to providing supporting evidence for well-established risk factors (smoking, alcohol, obesity, lack of physical activity), we also find sex steroid hormones, plasma lipids, and telomere length as determinants of cancer risk. A number of the molecular factors we identify may prove to be potential biomarkers. Our analysis, which highlights aetiological similarities and differences in common cancers, should aid public health prevention strategies to reduce cancer burden. We provide a R/Shiny app to visualise findings.